Key result
Elevated EASIX linked to ~2.3-fold higher major cardiovascular events risk in coronary slow-flow phenomenon.
Why the study?
Coronary slow flow phenomenon (CSFP) is increasingly considered a manifestation of endothelial and microvascular dysfunction, prompting this investigation into the prognostic value of the endothelial activation and stress index (EASIX) for major adverse cardiovascular events in patients with CSFP.
Does an elevated Endothelial Activation and Stress Index (EASIX > 1.03) predict major adverse cardiovascular events (MACE) in patients with angiographically confirmed coronary slow-flow phenomenon?
Cohort (n=517)
Blinded outcome assessment (angiograms reviewed independently by two experienced interventional cardiologists blinded to laboratory data and clinical outcomes)
No
Does an elevated Endothelial Activation and Stress Index (EASIX > 1.03) predict major adverse cardiovascular events (MACE) in patients with angiographically confirmed coronary slow-flow phenomenon?
An elevated Endothelial Activation and Stress Index (EASIX > 1.03), derived from routine laboratory parameters (LDH, creatinine, and platelets), is independently associated with a more than two-fold higher risk of MACE in patients with coronary slow-flow phenomenon and provides a high negative predictive value (96.1%) for risk stratification.
Answers are grounded in this paper and cite their sources.
Supports EASIX for risk stratification in coronary slow-flow; leaves open prospective validation before clinical adoption.
Background Coronary slow flow phenomenon (CSFP), defined by delayed distal opacification of epicardial coronary arteries without any identifiable mechanical cause, is increasingly considered as a manifestation of endothelial and microvascular dysfunction. In this study, we aimed to investigate the prognostic value of the endothelial activation and stress index (EASIX) in patients with CSFP. Methods We retrospectively analyzed 517 patients with angiographically confirmed CSFP. EASIX was calculated from lactate dehydrogenase, creatinine, and platelet count. The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of myocardial infarction (MI), stroke, or all-cause death. Data were analysed using Kaplan–Meier estimation, Cox proportional-hazards regression and receiver operating characteristic analysis. Results During a median follow-up of 27 months, MACE occurred in 47 patients (9.1%). MACE occurred in 23.2% of patients with EASIX > 1.03 versus 4.0% with EASIX ≤ 1.03 (p < 0.001), with higher rates of MI and stroke. Event-free survival was significantly lower in the high-EASIX group (log-rank p < 0.001). After adjustment for age, diabetes mellitus, smoking, estimated glomerular filtration rate, and high-sensitivity C-reactive protein, EASIX > 1.03 remained independently associated with MACE (hazard ratio 2.31, 95% confidence interval [CI] 1.06–5.00; p = 0.034). EASIX discriminated MACE with an area under the curve of 0.757 (95% CI 0.677–0.829), with 68.1% sensitivity and 77.7% specificity. Mean TIMI frame count and multivessel involvement were not prognostic. Conclusions Higher EASIX was independently associated with MACE in patients with CSFP and may provide a simple, readily available indicator for long-term risk stratification.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2026) conducted a cohort in Coronary slow-flow phenomenon (CSFP) (n=517). High Endothelial Activation and Stress Index (EASIX > 1.03) vs. Low Endothelial Activation and Stress Index (EASIX <= 1.03) was evaluated on Major adverse cardiovascular events (MACE), defined as a composite of myocardial infarction, stroke, or all-cause death (HR 2.31, 95% CI 1.06-5.00, p=0.034). An EASIX > 1.03 was independently associated with a higher risk of major cardiovascular events in patients with coronary slow-flow phenomenon.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: